4.7 Review

Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome

期刊

FREE RADICAL BIOLOGY AND MEDICINE
卷 114, 期 -, 页码 52-61

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2017.10.341

关键词

Neurotrophin; Signaling endosome; Down syndrome; Alzheimer's disease; Endosome enlargement; Axonal transport deficit; Degeneration

资金

  1. NIH [NS066072, EY016525, NS092525]
  2. Alzheimer's Association
  3. LuMind/RDS foundation
  4. NATIONAL EYE INSTITUTE [PN1EY016525] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS092525, R01NS066072] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Neurotrophic factors, including the members of the neurotrophin family, play important roles in the development and maintenance of the nervous system. Trophic factor signals must be transmitted over long distances from axons and dendrites to the cell bodies of neurons. A mode of signaling well suited to the challenge of robust long distance signaling is the signaling endosome. We review the biology of signaling endosomes and the signaling endosome hypothesis. Evidence for disruption of signaling endosome function in disorders of the nervous system is also reviewed. Changes in endosome structure in Alzheimer disease (AD) and Down syndrome (DS) are present early in these disorders. Data for the APP products responsible are reviewed and the consequent changes in signaling from endosomes discussed. We conclude by pointing to the need for additional studies to explore the biology of signaling endosomes in normal neurons and to elucidate their role in the pathogenesis of neurodegeneration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据